The deleterious effect of high concentrations of D-glucose requires pro-inflammatory preconditioning

J Hypertens. 2008 Mar;26(3):478-85. doi: 10.1097/HJH.0b013e3282f331fb.

Abstract

Objectives: The present study investigated whether high concentrations of D-glucose can trigger pro-inflammatory mechanisms in human aortic smooth muscle cells.

Methods: The expression and/or the activity of inducible nitric oxide synthase (iNOS), the extracellular signal-regulated kinase (ERK) 1/2 and nuclear factor (NF)-kappaB were studied in cultured human aortic smooth muscle cells (HASMC) in response to increasing concentrations of D-glucose and/or the inflammatory cytokine interleukin (IL)-1beta.

Results: Increasing D-glucose in the medium from 5.5 to 22 mmol/l had no effect on any of these parameters. However, the high concentration of D-glucose did increase iNOS expression in response to low concentrations of IL-1beta (2.5 and 5 ng/ml), as well as the IL-1beta-induced activation of both ERK 1/2 and NF-kappaB. D-glucose also enhanced, concentration-dependently, the expression and activity of iNOS induced by co-incubation with IL-1beta (10 ng/ml). Pretreatment with IL-1beta sensitized the cells to the subsequent effects of high D-glucose.

Conclusions: The results indicate that high concentrations of D-glucose exacerbate the pro-inflammatory effects of IL-1beta. We suggest that the observed association between inflammation and diabetes is the result of elevated D-glucose enhancing a pre-existing inflammatory condition, rather than a direct effect of D-glucose on the production of inflammatory mediators.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aorta
  • Cells, Cultured
  • Gene Expression
  • Glucose / pharmacology*
  • Humans
  • Interleukin-1beta / metabolism
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / immunology
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / metabolism*
  • NF-kappa B / biosynthesis*
  • Nitric Oxide Synthase / biosynthesis*
  • Phosphotransferases / biosynthesis*

Substances

  • Interleukin-1beta
  • NF-kappa B
  • Nitric Oxide Synthase
  • Phosphotransferases
  • Glucose